Rivaroxaban Completed Phase N/A Trials for Pulmonary Embolism / Deep Vein Thrombosis (DVT) and / or Pulmonary Embolism (PE) / Deep Vein Thrombosis / Venous Thromboembolism

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02210819Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
NCT03214172Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
NCT00831714Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty
NCT01029743Xarelto Regulatory Post-Marketing Surveillance